Chagas Disease A Clinical Approach /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Altcheh, Jaime Marcelo (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Freilij, Hector (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Σειρά: Birkhäuser Advances in Infectious Diseases,
• Θέματα: Molecular biology.; Parasitology.; Infectious diseases.; Molecular Medicine.; Infectious Diseases.

Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Europe, with an estimated 7 million people infected w...

Πίνακας περιεχομένων:

• Overview
• Chapter 1: Chagas disease: past, present and future
• The agent
• Chapter 2: Trypanosoma cruzi Journey from the Insect Vector to the Host Cell
• Chapter 3: A panoramic view of the immune response to Trypanosoma cruzi infection
• Epidemiology
• Chapter 4: Epidemiology of Chagas Disease
• Chapter 5: Chagas Disease in Europe
• Chapter 6: Chagas Disease in the United States (USA)
• Diagnosis
• Chapter 7: Diagnosis of Chagas disease
• Clinical aspects
• Chapter 8: Acute vector-borne Chagas disease
• Chapter 9: Congenital Chagas Disease
• Chapter 10: Chronic Trypanosoma cruzi Infection: Decision Making in the Midst of Uncertainty
• Chapter 11: Orally-Transmitted Chagas Disease: a Neglected Foodborne Infection
• Chapter 12: Gastrointestinal Chagas Disease
• Chapter 13: Chagas in immunosuppressed patients
• Treatment
• Chapter 14: CLINICAL PHARMACOLOGY OF DRUGS FOR THE TREATMENT OF CHAGAS DISEASE
• Chapter 15: In vivo Drug Testing for Experimental Trypanosoma cruzi Infection
• Chapter 16: Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities.